|
WO2020261231A1
|
|
Chimeric antigen receptor with 4-1bb costimulatory domain
|
|
WO2020171407A1
|
|
Composition comprising decursinol as active ingredient for prevention or treatment of thrombocytopenia or lymphopenia
|
|
CA3114402A1
|
|
Anti-human vsig4 antibodies and uses thereof
|
|
WO2020032780A1
|
|
Cancer antigen-specific cytotoxic t cells
|
|
CA3109209A1
|
|
Chimeric antigen receptor that binds hla-dr and car-t cell
|
|
WO2020032782A1
|
|
Method for preparing and cryopreserving cancer antigen-specific cd8+ t cells
|
|
EP3568469A1
|
|
Hla-dr car-t compositions and methods of making and using the same
|
|
EP3472209A1
|
|
Ifn- -inducible regulatory t cell convertible anti-cancer (irtca) antibody and uses thereof
|
|
US2018258177A1
|
|
Anti-human 4-1BB antibodies and uses thereof
|
